Definitive Healthcare (DH) Projected to Post Quarterly Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is expected to post its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect Definitive Healthcare to post earnings of $0.07 per share and revenue of $60.60 million for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.92 on Tuesday. The stock has a 50-day simple moving average of $4.61 and a 200 day simple moving average of $4.46. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The company has a market capitalization of $568.36 million, a PE ratio of -1.59, a P/E/G ratio of 4.06 and a beta of 1.45. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Insiders Place Their Bets

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. This represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 14.84% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on DH shares. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Barclays restated an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens initiated coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Two analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.